Research Projects
-
Andrew K. Godwin, PhD,
University of Kansas Medical Center Research Institute
Collaborative Research Development GrantTumor-Derived Extracellular Vesicle in Ovarian Cancer
-
Sohrab Shah, PhD,
Memorial Sloan Kettering Cancer Center
Collaborative Research Development GrantProfiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment
-
Ugo Cavallaro, PhD,
Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Fondazione Monzino
Collaborative Research Development GrantInterplay Between Ovarian Cancer Stem Cells and the Tumor Microenvironment
-
Sandra Orsulic, PhD,
UCLA School of Medicine
Collaborative Research Development GrantCo-Evolution of Epithelial Ovarian Cancer and Tumor Stroma
-
Kristin G. Anderson, PhD,
Fred Hutchinson Cancer Research Center
Mentored Investigator GrantEngineering Adoptive T Cell Therapy for Efficacy in Ovarian Cancer
-
Alexander Cole, PhD,
Magee-Womens Research Institute
Mentored Investigator GrantInvestigating Regulators of Quiescence in Epithelial Ovarian Cancer
-
Sarah Gitto, PhD,
University of Pennsylvania
Mentored Investigator GrantModeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
-
Guy Katz, MD, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantTherapeutic miRNA Targeting for Ovarian Cancer
-
Isaac Klein, MD, PhD,
Dana Farber Cancer Institute
Mentored Investigator GrantTranscriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
-
John Krais, PhD,
Fox Chase Cancer Center
Mentored Investigator GrantExamining the Role of RNF168 in BRCA1 Mutant Ovarian Cancer
-
Marilyne Labrie, PhD,
Oregon Health and Science University
Mentored Investigator GrantSynergistic Lethality of PARP and P13K Pathway Inhibitors in Ovarian Cancer
-
Jing Li, MD, PhD,
University of Michigan
Mentored Investigator GrantARID1A Drives Ovarian Cancer Immunotherapy